Simon H. Pearce
Centre Parkway
Newcastle Upon Tyne, ENG, United Kingdom
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Shorter Versus Standard Antithyroid Drug Therapy in Graves' Disease with Lower Baseline Thyrotropin Receptor Antibody (TRAb) Levels: Relapse Outcomes from a Propensity-Weighted Analysis.
Journal: Thyroid : official journal of the American Thyroid Association
Published: July 21, 2026
Future Therapies for Autoimmune Premature Ovarian Insufficiency.
Journal: NEJM evidence
Published: June 23, 2026
EndoCompass Project: Research Roadmap for Adrenal and Cardiovascular Endocrinology.
Journal: Hormone research in paediatrics
Published: October 14, 2025
Measuring Human Memory B Cells in Autoimmunity Using Enzyme-Linked ImmunoSpot.
Journal: Biomolecules
Published: April 08, 2025
Prevalence and severity of fatigue in treated hypothyroidism: results of a UK survey.
Journal: European thyroid journal
Published: February 07, 2025
EndoCompass project: research roadmap for adrenal and cardiovascular endocrinology.
Journal: European journal of endocrinology
Published: January 27, 2025
Exploring antigenic variation in autoimmune endocrinopathy.
Journal: Frontiers in immunology
Published: January 15, 2025
Variable hyperthyroidism outcomes related to different treatment regimens: an analysis of UK Biobank data.
Journal: European thyroid journal
Published: December 18, 2024
Mitotane dosage, plasma levels, and anthropometric measurements in pediatric adrenocortical carcinoma.
Journal: Endocrine oncology (Bristol, England)
Published: December 15, 2024
Inflammation-based score in pediatric adrenocortical carcinoma.
Journal: Endocrine-related cancer
Published: September 11, 2024
Changes in Thyroid Function and Autoimmunity in Older Individuals: Longitudinal Analysis of the Whickham Cohort.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 13, 2024
Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves' disease.
Journal: BMJ open
Published: June 12, 2024
Last Updated: 09/26/2026